Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1994 Jul;71(1):12–18. doi: 10.1136/adc.71.1.12

Comparative effect of two doses of growth hormone for growth hormone deficiency. The Dutch Growth Hormone Working Group.

S De Muinck Keizer-Schrama 1, B Rikken 1, A Hokken-Koelega 1, J M Wit 1, S Drop 1
PMCID: PMC1029904  PMID: 8067786

Abstract

The comparative effect and safety of 2 IU compared with 4 IU/m2/day of recombinant human growth hormone (rhGH) was studied in 38 growth hormone deficient children regarding the impact of several factors on short term (one year) and long term (three year) growth response. In 21 newly diagnosed patients, three years of rhGH treatment resulted in a significant increase of height velocity SD score, height SD score, and predicted adult height SD score, irrespective of rhGH dose. In 17 transfer patients (previously treated with 12 IU rhGH/m2/week) 4 IU/m2/day resulted in a significantly higher height velocity SD score and height SD score for chronological age than 2 IU/m2/day, while more of them reached their target range or showed a substantial height SD score increment. Height SD score for bone age and predicted adult height SD score only increased significantly with 4 IU rhGH. After one year of rhGH treatment, new patients showed significant negative correlation between delta height SD score with age and baseline insulin-like growth factor I (IGF-I) SD score, and positive correlation with rhGH dose. After three years of treatment, delta height SD score for chronological age was significantly, negatively correlated with age and baseline 'corrected' height SD score (height SD score for chronological age minus target height SD score). There was no significant correlation with rhGH dose. Prolonged treatment with either dose had no adverse effect on IGF-I concentrations, carbohydrate or lipid metabolism. As early age and divergence between height SD score and target height SD score seem more important for growth response than rhGH dose, it is recommended that treatment starts early with 2 IU rhGH/m(2)/day and the dose is doubled if growth is insufficient after several years of treatment.

Full text

PDF
12

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albertsson-Wikland K., Westphal O., Westgren U. Daily subcutaneous administration of human growth hormone in growth hormone deficient children. Acta Paediatr Scand. 1986 Jan;75(1):89–97. doi: 10.1111/j.1651-2227.1986.tb10163.x. [DOI] [PubMed] [Google Scholar]
  2. Asayama K., Amemiya S., Kusano S., Kato K. Growth-hormone-induced changes in postheparin plasma lipoprotein lipase and hepatic triglyceride lipase activities. Metabolism. 1984 Feb;33(2):129–131. doi: 10.1016/0026-0495(84)90124-0. [DOI] [PubMed] [Google Scholar]
  3. Blackett P. R., Weech P. K., McConathy W. J., Fesmire J. D. Growth hormone in the regulation of hyperlipidemia. Metabolism. 1982 Feb;31(2):117–120. doi: 10.1016/0026-0495(82)90121-4. [DOI] [PubMed] [Google Scholar]
  4. Christiansen J. S., Orskov H., Binder C., Kastrup K. W. Imitation of normal plasma growth hormone profile by subcutaneous administration of human growth hormone to growth hormone deficient children. Acta Endocrinol (Copenh) 1983 Jan;102(1):6–10. doi: 10.1530/acta.0.1020006. [DOI] [PubMed] [Google Scholar]
  5. Frasier S. D. Human pituitary growth hormone (hGH) therapy in growth hormone deficiency. Endocr Rev. 1983 Spring;4(2):155–170. doi: 10.1210/edrv-4-2-155. [DOI] [PubMed] [Google Scholar]
  6. Kastrup K. W., Christiansen J. S., Andersen J. K., Orskov H. Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children. Acta Endocrinol (Copenh) 1983 Oct;104(2):148–152. doi: 10.1530/acta.0.1040148. [DOI] [PubMed] [Google Scholar]
  7. Merimee T. J. Familial combined hyperlipoproteinemia. Evidence for a role of growth hormone deficiency in effecting its manifestation. J Clin Invest. 1980 Apr;65(4):829–835. doi: 10.1172/JCI109734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Merimee T. J., Hollander W., Fineberg S. E. Studies of hyperlipidemia in the HGH-deficient state. Metabolism. 1972 Nov;21(11):1053–1061. doi: 10.1016/0026-0495(72)90036-4. [DOI] [PubMed] [Google Scholar]
  9. Miller G. J. High density lipoproteins and atherosclerosis. Annu Rev Med. 1980;31:97–108. doi: 10.1146/annurev.me.31.020180.000525. [DOI] [PubMed] [Google Scholar]
  10. Milner R. D., Russell-Fraser T., Brook C. G., Cotes P. M., Farquhar J. W., Parkin J. M., Preece M. A., Snodgrass G. J., Mason A. S., Tanner J. M. Experience with human growth hormone in Great Britain: the report of the MRC Working Party. Clin Endocrinol (Oxf) 1979 Jul;11(1):15–38. doi: 10.1111/j.1365-2265.1979.tb03043.x. [DOI] [PubMed] [Google Scholar]
  11. Ranke M. B., Guilbaud O. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first year of treatment with human growth hormone. Analysis of the Kabi International Growth Study. Acta Paediatr Scand Suppl. 1990;370:122–130. doi: 10.1111/j.1651-2227.1990.tb11689.x. [DOI] [PubMed] [Google Scholar]
  12. Rikken B., Wit J. M. Prepubertal height velocity references over a wide age range. Arch Dis Child. 1992 Oct;67(10):1277–1280. doi: 10.1136/adc.67.10.1277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Soyka L. F., Bode H. H., Crawford J. D., Flynn F. J., Jr Effectiveness of long-term human growth hormone therapy for short stature in children with growth hormone deficiency. J Clin Endocrinol Metab. 1970 Jan;30(1):1–14. doi: 10.1210/jcem-30-1-1. [DOI] [PubMed] [Google Scholar]
  14. Tanner J. M., Landt K. W., Cameron N., Carter B. S., Patel J. Prediction of adult height from height and bone age in childhood. A new system of equations (TW Mark II) based on a sample including very tall and very short children. Arch Dis Child. 1983 Oct;58(10):767–776. doi: 10.1136/adc.58.10.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Vanderschueren-Lodeweyckx M., Van den Broeck J., Wolter R., Malvaux P. Early initiation of growth hormone treatment: influence on final height. Acta Paediatr Scand Suppl. 1987;337:4–11. doi: 10.1111/j.1651-2227.1987.tb17121.x. [DOI] [PubMed] [Google Scholar]
  16. Winter R. J., Thompson R. G., Green O. C. Serum cholesterol and triglycerides in children with growth hormone deficiency. Metabolism. 1979 Dec;28(12):1244–1249. doi: 10.1016/0026-0495(79)90138-0. [DOI] [PubMed] [Google Scholar]
  17. de Muinck Keizer-Schrama S. M., Rikken B., Wynne H. J., Hokken-Koelega A. C., Wit J. M., Bot A., Drop S. L. Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group. J Clin Endocrinol Metab. 1992 Apr;74(4):898–905. doi: 10.1210/jcem.74.4.1548357. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES